New drugs added to OEP subsidy list

Over a hundred new pharmaceutical products, 80% of them generic, will be added to the National Health Fund Administration's (OEP) list of subsidized drugs next year, the OEP said yesterday. Since Hungary's EU entry in May, the number of subsidy applications by drug makers has risen to over 450 upon the adoption of the EU's drug transparency directives, which forced many pharmaceuticals to re-submit older applications. With more lower-price generic products set to be introduced on the market next year, the OEP expects medication prices to grow not more than 7% on average from January. (Vg 1) S.F.